Editorial: The risk-benefit balance of varenicline for smoking cessation

Research output: Contribution to journalArticle

5 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)949-950
Number of pages2
JournalJournal of Thoracic Oncology
Volume3
Issue number9
DOIs
StatePublished - Sep 2008

Fingerprint

Benzazepines
Quinoxalines
Smoking Cessation
Varenicline

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Editorial : The risk-benefit balance of varenicline for smoking cessation. / Hays, James Taylor.

In: Journal of Thoracic Oncology, Vol. 3, No. 9, 09.2008, p. 949-950.

Research output: Contribution to journalArticle

@article{1befba0277094d1d8cc50d7a04ed4032,
title = "Editorial: The risk-benefit balance of varenicline for smoking cessation",
author = "Hays, {James Taylor}",
year = "2008",
month = "9",
doi = "10.1097/JTO.0b013e31818593fc",
language = "English (US)",
volume = "3",
pages = "949--950",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "9",

}

TY - JOUR

T1 - Editorial

T2 - The risk-benefit balance of varenicline for smoking cessation

AU - Hays, James Taylor

PY - 2008/9

Y1 - 2008/9

UR - http://www.scopus.com/inward/record.url?scp=58149140385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149140385&partnerID=8YFLogxK

U2 - 10.1097/JTO.0b013e31818593fc

DO - 10.1097/JTO.0b013e31818593fc

M3 - Article

C2 - 18758294

AN - SCOPUS:58149140385

VL - 3

SP - 949

EP - 950

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 9

ER -